Kukreti V - Search Results

1

The Impact of CD34⁺ Cell Collection Yields for Autologous Transplant on Survival Outcomes in Multiple Myeloma.

Lebel E, Lajkosz K, Masih-Khan E, Reece D, Trudel S, Tiedemann R, Prica A, Kukreti V, Chen C. Lebel E, et al. Among authors: kukreti v. Clin Lymphoma Myeloma Leuk. 2023 Nov;23(11):850-856. doi: 10.1016/j.clml.2023.07.014. Epub 2023 Aug 14. Clin Lymphoma Myeloma Leuk. 2023. PMID: 37689547 Review.

2

Lenalidomide (Revlimid), bortezomib (Velcade) and dexamethasone for heavily pretreated relapsed or refractory multiple myeloma.

Jimenez-Zepeda VH, Reece DE, Trudel S, Chen C, Tiedemann R, Kukreti V. Jimenez-Zepeda VH, et al. Among authors: kukreti v. Leuk Lymphoma. 2013 Mar;54(3):555-60. doi: 10.3109/10428194.2012.719614. Epub 2013 Jan 2. Leuk Lymphoma. 2013. PMID: 22881043

3

Rapidity and quality of response to steroid-based induction therapy, without the addition of novel agents, does not affect post transplant outcomes in multiple myeloma.

Prica A, Trieu Y, Xu W, Reece DE, Trudel S, Kukreti V, Chen C. Prica A, et al. Among authors: kukreti v. Clin Lymphoma Myeloma Leuk. 2013 Feb;13(1):25-31. doi: 10.1016/j.clml.2012.08.008. Epub 2012 Oct 27. Clin Lymphoma Myeloma Leuk. 2013. PMID: 23107916

4

Oligoclonal and monoclonal bands after single autologous stem cell transplant in patients with multiple myeloma: impact on overall survival and progression-free survival.

Jimenez-Zepeda VH, Reece DE, Trudel S, Franke N, Winter A, Chen C, Tiedemann R, Kukreti V. Jimenez-Zepeda VH, et al. Among authors: kukreti v. Leuk Lymphoma. 2014 Oct;55(10):2284-9. doi: 10.3109/10428194.2013.873537. Epub 2014 Feb 24. Leuk Lymphoma. 2014. PMID: 24354684

5

Intermittent granulocyte colony-stimulating factor for neutropenia management in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone.

Sun HL, Atenafu EG, Yeboah E, Reece DE, Trudel S, Kukreti V, Masih-Khan E, Winter A, Chen C. Sun HL, et al. Among authors: kukreti v. Leuk Lymphoma. 2015 Feb;56(2):407-14. doi: 10.3109/10428194.2014.915544. Epub 2014 Jul 7. Leuk Lymphoma. 2015. PMID: 24738975

6

Absolute lymphocyte count as predictor of overall survival for patients with multiple myeloma treated with single autologous stem cell transplant.

Jimenez-Zepeda VH, Reece DE, Trudel S, Chen C, Franke N, Winter A, Tiedemann R, Kukreti V. Jimenez-Zepeda VH, et al. Among authors: kukreti v. Leuk Lymphoma. 2015;56(9):2668-73. doi: 10.3109/10428194.2014.1003057. Epub 2015 Feb 24. Leuk Lymphoma. 2015. PMID: 25573201

7

Cyclophosphamide and Bortezomib With Prednisone or Dexamethasone for the Treatment of Relapsed and Refractory Multiple Myeloma.

Reece DE, Trieu Y, Masih-Khan E, Atenafu EG, Chen C, Prica A, Tiedemann R, Trudel S, Kukreti V. Reece DE, et al. Among authors: kukreti v. Clin Lymphoma Myeloma Leuk. 2016 Jul;16(7):387-94. doi: 10.1016/j.clml.2016.04.012. Epub 2016 May 10. Clin Lymphoma Myeloma Leuk. 2016. PMID: 27349765

8

Single-center Experience in Treating Patients With t(4;14) Multiple Myeloma With and Without Planned Frontline Autologous Stem Cell Transplantation.

Chan H, Phillips M, Maganti M, Farooki S, Piza Rodriguez G, Masih-Khan E, Chen C, Prica A, Reece D, Tiedemann R, Trudel S, Kukreti V. Chan H, et al. Among authors: kukreti v. Clin Lymphoma Myeloma Leuk. 2018 Mar;18(3):225-234. doi: 10.1016/j.clml.2017.12.009. Epub 2018 Jan 5. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29397346

9

Addition of Cyclophosphamide "On Demand" to Lenalidomide and Corticosteroids in Patients With Relapsed/Refractory Multiple Myeloma-A Retrospective Review of a Single-center Experience.

Alahmadi M, Masih-Khan E, Atenafu EG, Chen C, Kukreti V, Tiedemann R, Trudel S, Reece DE. Alahmadi M, et al. Among authors: kukreti v. Clin Lymphoma Myeloma Leuk. 2019 Apr;19(4):e195-e203. doi: 10.1016/j.clml.2018.12.007. Epub 2018 Dec 20. Clin Lymphoma Myeloma Leuk. 2019. PMID: 30723035

10

Toxicity and survival outcomes of autologous stem cell transplant in multiple myeloma patients with renal insufficiency: an institutional comparison between two eras.

Li AY, Atenafu EG, Bernard RS, Masih-Khan E, Reece D, Franke N, Tiedemann R, Prica A, Trudel S, Kukreti V, Chen CI. Li AY, et al. Among authors: kukreti v. Bone Marrow Transplant. 2020 Mar;55(3):578-585. doi: 10.1038/s41409-019-0697-8. Epub 2019 Sep 26. Bone Marrow Transplant. 2020. PMID: 31558786

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

137 results

Search Page